Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 20.42%34.5M | 78.29%34.34M | 108.69%62.06M | -41.25%135.48M | -25.22%60.09M | -49.40%28.65M | -37.57%19.26M | -52.63%29.74M | 43.73%230.61M | 150.49%80.35M |
| Cost of revenue | 17.01%30.44M | 92.25%31.15M | 117.05%55.55M | -44.62%118.61M | -32.82%53.05M | -49.02%26.02M | -42.26%16.2M | -54.38%25.59M | 61.09%214.17M | 68.41%78.97M |
| Gross profit | 54.12%4.06M | 4.29%3.19M | 57.09%6.51M | 2.57%16.87M | 409.34%7.03M | -52.91%2.63M | 9.69%3.06M | -37.99%4.15M | -40.19%16.45M | 109.32%1.38M |
| Operating expense | -58.06%2.21M | -54.45%2.73M | -24.45%6M | 2.96%33.13M | -1.04%9.81M | -22.10%5.28M | -20.48%5.98M | 4.61%7.94M | 10.76%32.18M | 6,982.80%9.92M |
| Selling and administrative expenses | -48.82%2.79M | 1.25%6.24M | -21.35%6.38M | -8.69%29.78M | -4.00%9.9M | -21.22%5.46M | -20.24%6.16M | 4.90%8.11M | 11.58%32.62M | 24.21%10.31M |
| -General and administrative expense | -48.82%2.79M | 1.25%6.24M | -21.35%6.38M | -8.69%29.78M | -4.00%9.9M | -21.22%5.46M | -20.24%6.16M | 4.90%8.11M | 11.58%32.62M | 24.21%10.31M |
| Other operating expenses | ---- | ---- | ---- | 1,264.62%4.04M | -74.81%67K | ---- | ---- | ---- | -47.73%296.05K | 103.22%266K |
| Total other operating income | 219.23%581K | 1,831.87%3.52M | 117.51%385K | -5.97%694.34K | -76.97%152K | 17.42%182K | -11.22%182K | 19.59%177K | -1.56%738.41K | 717.43%660K |
| Operating profit | 169.78%1.85M | 115.83%463K | 113.64%517K | -3.37%-16.26M | 67.45%-2.78M | -123.69%-2.64M | 38.24%-2.93M | -321.11%-3.79M | -913.15%-15.73M | 42.93%-8.53M |
| Net non-operating interest income (expenses) | -46.80%516K | 72.91%1.51M | 57.13%1.75M | 34.99%3.36M | 202.31%398K | 123.26%970K | -82.80%875K | -27.17%1.12M | 181.23%2.49M | 81.57%-389K |
| Non-operating interest income | -12.17%6.07M | -12.00%6.04M | -3.57%6.86M | -1.63%27.79M | -7.03%6.9M | 72.27%6.91M | -29.88%6.87M | 1.60%7.11M | 46.89%28.25M | 46.63%7.42M |
| Non-operating interest expense | -6.52%5.55M | -24.40%4.53M | -14.86%5.11M | -3.86%23.22M | -16.76%6.5M | -27.41%5.94M | 27.27%5.99M | 9.66%6M | 43.82%24.15M | 39.01%7.81M |
| Total other finance cost | ---- | ---- | ---- | -24.74%1.21M | ---- | ---- | ---- | ---- | 3.63%1.61M | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -619.48%-5.8M | -719.07%-5.8M | 16.04%-806K | -708K | ||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -615.24%-5.77M | -3.97M | -806.4K | 0 | ||||||
| Less:Impairment of capital assets | ---- | ---- | ---- | --3.97M | --3.97M | ---- | ---- | ---- | --0 | --0 |
| Less:Write off | ---- | ---- | ---- | 615.24%5.77M | ---- | ---- | ---- | ---- | --806.4K | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | 241.04%2.36M | 196.44%1.98M | 184.79%2.27M | -32.89%-18.67M | -26.18%-12.15M | 68.72%-1.67M | -685.71%-2.05M | -523.93%-2.68M | -762.91%-14.05M | 46.57%-9.63M |
| Income tax | 195.06%1.38M | 47.53%1.38M | -35.74%1.05M | 119.72%5.67M | 733.81%2.32M | -79.69%466K | 15,433.33%932K | 54,366.67%1.63M | -42.60%2.58M | -72.34%278K |
| Net income | 146.07%986K | 120.15%601K | 128.27%1.22M | -46.37%-24.34M | -46.03%-14.47M | 72.02%-2.14M | -966.86%-2.98M | -786.15%-4.31M | -171.45%-16.63M | 47.93%-9.91M |
| Net income continuous operations | 146.07%986K | 120.19%602K | 128.27%1.22M | -46.37%-24.34M | -46.03%-14.47M | 72.02%-2.14M | -966.86%-2.98M | -786.15%-4.31M | -171.45%-16.63M | 47.93%-9.91M |
| Noncontrolling interests | -1K | -1K | 0.00%-1K | -28.67%4.85K | 16.67%-5K | 0 | 0 | -1K | 6.79K | -6K |
| Net income attributable to the company | 146.12%987K | 120.19%602K | 128.30%1.22M | -46.34%-24.35M | -46.07%-14.47M | 72.02%-2.14M | -966.86%-2.98M | -785.99%-4.31M | -171.56%-16.64M | 47.96%-9.9M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 146.12%987K | 120.19%602K | 128.30%1.22M | -46.34%-24.35M | -46.07%-14.47M | 72.02%-2.14M | -966.86%-2.98M | -785.99%-4.31M | -171.56%-16.64M | 47.96%-9.9M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 146.16%0.0003 | 120.00%0.0002 | 128.57%0.0004 | -41.07%-0.0079 | -42.42%-0.0047 | 73.42%-0.0007 | -1,100.00%-0.001 | -800.00%-0.0014 | -143.48%-0.0056 | 52.86%-0.0033 |
| Diluted earnings per share | 146.16%0.0003 | 120.00%0.0002 | 128.57%0.0004 | -41.07%-0.0079 | -42.42%-0.0047 | 73.42%-0.0007 | -1,100.00%-0.001 | -800.00%-0.0014 | -143.48%-0.0056 | 52.86%-0.0033 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.